16.06.2008 12:00:00
|
CIGNA HealthCare Selects GI Pathology, PLLC as a National Gastrointestinal Pathology Provider
GI Pathology, PLLC announced today that it has entered into a new,
national agreement (Agreement) with CIGNA HealthCare ("CIGNA”),
an affiliate of CIGNA Corporation (NYSE: CI), effective June 15, 2008.
Under the terms of the Agreement, GI Pathology, PLLC will become a
participating gastrointestinal pathology laboratory for CIGNA.
"We are very pleased to have been selected by
CIGNA as a national pathology provider within their laboratory network,”
commented Patrick J. Dean, M.D., Chairman of GI Pathology, PLLC. "Our
relationship with CIGNA is an important step towards delivering
sub-specialized pathology nationwide.” "GI Pathology has a commitment to delivering
the highest quality gastrointestinal pathology diagnoses to our GI
clients,” Dean added. "Our
agreement with CIGNA recognizes our commitment and the value of the
benefits we deliver to CIGNA and its members.” About CIGNA HealthCare, Inc.
CIGNA HealthCare, based in Bloomfield, CT, provides medical benefits
plans, dental coverage, behavioral health coverage, pharmacy benefits
and products and services that integrate and analyze information to
support consumerism and health advocacy. "CIGNA HealthCare" refers to
certain operations of Connecticut General Life Insurance Company, which
is an operating subsidiary of CIGNA Corporation (NYSE:CI).
Products and services are provided by such operating subsidiaries, and
not by CIGNA Corporation. For more information, visit http://www.CIGNA.com.
About GI Pathology, PLLC
Founded in 1995, GI Pathology is the only physician-owned laboratory in
the United States dedicated solely to the practice of gastrointestinal
and liver pathology. The company provides the highest quality GI
pathology diagnoses, made exclusively by one of its fellowship-trained
gastrointestinal and liver pathologists. Centrally located in Memphis,
Tennessee, the company guarantees that pathology results will be
delivered back to its nationwide client base within an industry-leading
24 hours. For more information, visit the company website at http://www.gipath.com.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Nachrichten zu Cigna Corpmehr Nachrichten
Keine Nachrichten verfügbar. |